Vor BioPharma Shares Surge 33% After Special Sale

Investing.com -- Shares of Vor BioPharma saw a significant increase of up to 33% on Friday following the announcement of the company's $55.6 million private stock sale. According to the terms of the agreement, Vor Bio will issue approximately 55.9 million shares of common stock and about 69.8 million warrants that provide the right to purchase shares. Additionally, Vor announced plans to release updated clinical data from the VBP301 and VBP101 trials next year. The funds raised from the private sale are expected to extend Vor's cash runway until the release of updated data from the VBP301 and VBP101 trials in 2025.